HU-6
- Generic Name
- HU-6
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Rivus Pharmaceuticals, Inc.
- Registration Number
- NCT06104358
- Locations
- ๐บ๐ธ
AdventHealth Translational Research Institute, Orlando, Florida, United States
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
- Conditions
- Fatty LiverNon-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
- Interventions
- Other: Placebo
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Rivus Pharmaceuticals, Inc.
- Target Recruit Count
- 219
- Registration Number
- NCT05979779
- Locations
- ๐บ๐ธ
Velocity Clinical Research, Los Angeles, California, United States
๐บ๐ธPanax Clinical Research, Miami Lakes, Florida, United States
๐บ๐ธCenExel HRI, Berlin, New Jersey, United States
Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF
- Conditions
- Heart Failure With Preserved Ejection Fraction
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Rivus Pharmaceuticals, Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT05284617
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States
๐บ๐ธWeill Cornell Medicine, New York, New York, United States
Phase 2a Study of HU6 in Subjects With Elevated Liver Fat and High BMI Volunteers
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Rivus Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04874233
- Locations
- ๐บ๐ธ
Prism Clinical Research, Minneapolis, Minnesota, United States
Multiple Ascending Dose Study of HU6 in High BMI Volunteers
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Rivus Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04709913
- Locations
- ๐บ๐ธ
Prism Clinical Research, Minneapolis, Minnesota, United States
Ascending Dose Study of HU6 in Healthy Volunteers
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Rivus Pharmaceuticals, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT04463017
- Locations
- ๐บ๐ธ
Prism Clinical Research, Saint Paul, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.